STAT BRCA1 and BRCA2 Cancer Panel
An expedited 2-gene panel for rapid evaluation of hereditary breast and ovarian cancer (HBOC) risk, delivering accelerated results powered by the Helix Exome+® platform.
6-11 days
≤ 2 days
Panel Description
This STAT panel evaluates 2 genes associated with hereditary breast and ovarian cancer (HBOC) and delivers expedited results to enable accelerated clinical intervention.
Have Questions?
Our team is available Monday through Friday, 9am-5pm Pacific Time.
Indications for Testing
A relevant personal and/or family history suggestive of a hereditary form of cancer.
Methodology
This test utilizes next-generation sequencing to detect single nucleotide variants, insertions and deletions up to 20 bp, and copy number variants in genes associated with hereditary breast and ovarian cancer (HBOC).
Technical Specifications
> 99%
> 99%
> 99%
> 99%
> 90%
BRCA1: sequencing analysis extends to CDS +/-20 bp; BRCA2: analysis includes detection of c.156_157insAlu and sequencing analysis extends to CDS +/-20 bp....
GRCh38
Genes Tested
Showing 2 of 2 genes in this panel